{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:30:42Z","timestamp":1789785042179,"version":"4.0.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tips.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T23:07:26Z","timestamp":1462489646000},"page":"543-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Clinical Potential of Neurosteroids for CNS Disorders"],"prefix":"10.1016","volume":"37","author":[{"given":"Doodipala Samba","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2016.04.003_bib0660","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Progr. Brain Res."},{"key":"10.1016\/j.tips.2016.04.003_bib0665","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fendo.2011.00038","article-title":"Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy","volume":"2","author":"Reddy","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tips.2016.04.003_bib0670","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.94.2430.94","article-title":"On the hormonal activity of a steroid compound","volume":"94","author":"Selye","year":"1941","journal-title":"Science"},{"key":"10.1016\/j.tips.2016.04.003_bib0675","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.96.2494.358","article-title":"Additional steroids with luteoid activity","volume":"96","author":"Selye","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.tips.2016.04.003_bib0680","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/bja\/45.3.237","article-title":"Anaesthesia and carbohydrate metabolism","volume":"45","author":"Clarke","year":"1973","journal-title":"Br. J. Anesthesiol."},{"key":"10.1016\/j.tips.2016.04.003_bib0685","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00000542-197503000-00017","article-title":"Steroid anesthetics","volume":"42","author":"Gyermek","year":"1975","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tips.2016.04.003_bib0690","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(84)90299-3","article-title":"Modulation of the GABA receptor complex by a steroid anaesthetic","volume":"323","author":"Harrison","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2016.04.003_bib0695","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.tips.2016.04.003_bib0700","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevNeurobiol.v15.i34.20","article-title":"Pharmacology of endogenous neuroactive steroids","volume":"15","author":"Reddy","year":"2003","journal-title":"Crit. Rev. Neuobiol."},{"key":"10.1016\/j.tips.2016.04.003_bib0705","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1007\/s00213-014-3494-5","article-title":"Pharmacological profile of a 17\u03b2-heteroaryl-substituted neuroactive steroid","volume":"231","author":"Hogenkamp","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib0710","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1358\/dof.2004.029.03.793135","article-title":"Ganaxolone: a prospective overview","volume":"29","author":"Reddy","year":"2004","journal-title":"Drugs of the Future"},{"key":"10.1016\/j.tips.2016.04.003_bib0715","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0079-6468(08)70059-6","article-title":"Development of neurosteroid-based novel psychotropic drugs","volume":"37","author":"Reddy","year":"2000","journal-title":"Progr. Med. Chem."},{"key":"10.1016\/j.tips.2016.04.003_bib0720","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neuroscience.2005.10.016","article-title":"Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions","volume":"138","author":"Reddy","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2016.04.003_bib0725","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2014.08.003","article-title":"Altered expression of \u03b4GABA-A receptors in health and disease","volume":"88","author":"Whissell","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib0730","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0079-6123(07)63014-3","article-title":"Functional regulation of the dentate gyrus by GABA-mediated inhibition","volume":"163","author":"Coulter","year":"2007","journal-title":"Progr. Brain Res."},{"key":"10.1016\/j.tips.2016.04.003_bib0735","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1523\/JNEUROSCI.4751-07.2008","article-title":"Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?","volume":"28","author":"Glykys","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0740","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA-A receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib0745","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tins.2010.03.005","article-title":"The sticky issue of neurosteroids and GABA-A receptors","volume":"33","author":"Chisari","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0750","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABA-A receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol. Therap."},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2016.04.003_bib0755","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.psyneuen.2009.05.020","article-title":"The influence of the membrane on neurosteroid actions at GABA-A receptors","volume":"34","author":"Akk","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tips.2016.04.003_bib0760","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuint.2007.10.007","article-title":"Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease","volume":"52","author":"Mitchell","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tips.2016.04.003_bib0765","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-6147(03)00023-3","article-title":"Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?","volume":"24","author":"Reddy","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2016.04.003_bib0770","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.04.003_bib0775","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2008.07.050","article-title":"Conserved site for neurosteroid modulation of GABA-A receptors","volume":"56","author":"Hosie","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib0780","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","article-title":"Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation","volume":"270","author":"Kokate","year":"1994","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0785","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/jm9605344","article-title":"3 Alpha-hydroxy-3 beta-(phenylethynyl)-5 beta-pregnan-20-ones: synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors","volume":"40","author":"Upasani","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2016.04.003_bib0790","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/jpet.110.169854","article-title":"The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors","volume":"334","author":"Reddy","year":"2010","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0795","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0022-3565(24)39327-9","article-title":"Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia","volume":"293","author":"Covey","year":"2000","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0800","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/jm401577c","article-title":"Neurosteroid analogues. 18. Structure\u2013activity studies of ent-steroid potentiators of gamma-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone","volume":"57","author":"Qian","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2016.04.003_bib0805","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1523\/JNEUROSCI.22-09-03795.2002","article-title":"Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility","volume":"22","author":"Reddy","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0810","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0896-6273(90)90202-Q","article-title":"Neurosteroids act on recombinant human GABA-A receptors","volume":"4","author":"Puia","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2016.04.003_bib0815","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1528-1167.2010.02870.x","article-title":"Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy","volume":"51","author":"Reddy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib0820","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA-A receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2016.04.003_bib0825","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1152\/jn.00450.2011","article-title":"Molecular basis for the high THIP\/gaboxadol sensitivity of extrasynaptic GABA-A receptors","volume":"106","author":"Meera","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2016.04.003_bib0830","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.115.229302","article-title":"Neurosteroid structure\u2013activity relationships for functional activation of extrasynaptic \u03b4GABA-A receptors","volume":"357","author":"Carver","year":"2016","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0835","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/jpet.114.222075","article-title":"Antiseizure activity of midazolam in mice lacking delta-subunit extrasynaptic GABA(A) receptors","volume":"353","author":"Reddy","year":"2015","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0840","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1523\/JNEUROSCI.23-34-10934.2003","article-title":"Neurosteroids shift partial agonist activation of GABA-A receptor channels from low- to high-efficacy gating patterns","volume":"23","author":"Bianchi","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0845","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1523\/JNEUROSCI.3684-08.2009","article-title":"Changes in expression and function of extrasynaptic GABAA receptors in the rat hippocampus during pregnancy and after delivery","volume":"29","author":"Sanna","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0850","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.113.203653","article-title":"Estrous cycle regulation of extrasynaptic delta-containing GABA-A receptor-mediated tonic inhibition and limbic epileptogenesis","volume":"346","author":"Wu","year":"2013","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0855","doi-asserted-by":"crossref","first-page":"14181","DOI":"10.1523\/JNEUROSCI.0596-14.2014","article-title":"Perimenstrual-like hormonal regulation of extrasynaptic delta-containing GABA-A receptors mediating tonic inhibition and neurosteroid sensitivity","volume":"34","author":"Carver","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0860","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","article-title":"Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice","volume":"96","author":"Mihalek","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tips.2016.04.003_bib0865","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1152\/jn.01022.2002","article-title":"Reduced inhibition and sensitivity to neurosteroids in hippocampus of mice lacking the GABA(A) receptor delta subunit","volume":"90","author":"Spigelman","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2016.04.003_bib0870","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABA-A receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tips.2016.04.003_bib0875","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1152\/jn.00727.2012","article-title":"Dual mechanisms diminishing tonic GABA-A inhibition of dentate gyrus granule cells in Noda epileptic rats","volume":"110","author":"Pandit","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2016.04.003_bib0880","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/hmg\/ddh146","article-title":"GABRD encoding a protein for extra- or peri-synaptic GABA-A receptors is a susceptibility locus for generalized epilepsies","volume":"13","author":"Dibbens","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2016.04.003_bib0885","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1523\/JNEUROSCI.2913-05.2006","article-title":"Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABA-A receptors","volume":"26","author":"Feng","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0890","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuint.2007.05.019","article-title":"Mass spectrometric assay and physiological\u2013pharmacological activity of androgenic neurosteroids","volume":"52","author":"Reddy","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tips.2016.04.003_bib0895","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eplepsyres.2004.09.003","article-title":"Role of neurosteroids in catamenial epilepsy","volume":"62","author":"Reddy","year":"2004","journal-title":"Epilepsy research"},{"key":"10.1016\/j.tips.2016.04.003_bib0900","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1358\/mf.2004.26.7.863737","article-title":"Pharmacology of catamenial epilepsy","volume":"26","author":"Reddy","year":"2004","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2016.04.003_bib0905","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1528-1167.2005.00705.x","article-title":"Anticonvulsant activity of androsterone and etiocholanolone","volume":"46","author":"Kaminski","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib0910","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.0013-9580.2004.04504.x","article-title":"Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice","volume":"45","author":"Kaminski","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib0915","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-3565(24)39026-3","article-title":"Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself","volume":"295","author":"Reddy","year":"2000","journal-title":"Th J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0920","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1528-1157.2001.10200.x","article-title":"Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy","volume":"42","author":"Reddy","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib0925","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13556219772516","article-title":"Modulation of the decrease in the seizure threshold of pentylenetetrazole in diazepam withdrawn mice by the neurosteroid 5alphapregnan-3alpha, 21-diol-20-one (alloTHDOC)","volume":"2","author":"Tsuda","year":"1997","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2016.04.003_bib0930","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-3565(25)20630-9","article-title":"Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal","volume":"278","author":"Devaud","year":"1996","journal-title":"Th J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0935","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3565(24)37827-9","article-title":"Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice","volume":"287","author":"Kokate","year":"1998","journal-title":"T J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0940","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3565(24)39152-9","article-title":"Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy","volume":"294","author":"Reddy","year":"2000","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib0945","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuropharm.2010.08.017","article-title":"Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis","volume":"59","author":"Reddy","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib0950","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1523\/JNEUROSCI.4488-10.2011","article-title":"Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors","volume":"31","author":"Reddy","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib0955","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/13543784.8.10.1663","article-title":"Ganaxolone: a novel positive allosteric modulator of the GABA-A receptor complex for the treatment of epilepsy","volume":"8","author":"Monaghan","year":"1999","journal-title":"Expert Opin. Investig Drugs"},{"key":"10.1016\/j.tips.2016.04.003_bib0960","series-title":"American Epilepsy Society Annual Meeting Abstracts","article-title":"Outpatient flexible dose, open-label add-on ganaxolone in treatment-refractory pediatric epilepsy","author":"Tsai","year":"2006"},{"key":"10.1016\/j.tips.2016.04.003_bib0965","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1528-1167.2007.01182.x","article-title":"Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy","volume":"48","author":"Pieribone","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib0970","series-title":"American Epilepsy Society Annual Meeting Abstracts","article-title":"Inpatient flexible dose, open-label add-on ganaxolone in treatment-refractory pediatric epilepsy","author":"Giller","year":"2006"},{"key":"10.1016\/j.tips.2016.04.003_bib0975","series-title":"American Epilepsy Society Annual Meeting Abstracts","article-title":"An open-label extension study to evaluate the safety, tolerability, and efficacy of ganaxolone as add-on therapy in adults with uncontrolled partial onset seizures","author":"Tsai","year":"2010"},{"key":"10.1016\/j.tips.2016.04.003_bib0980","series-title":"American Epilepsy Society Annual Meeting Abstracts","article-title":"Ganaxolone is safe and well-tolerated as add-on therapy in adults in uncontrolled partial seizures","author":"Tsai","year":"2011"},{"key":"10.1016\/j.tips.2016.04.003_bib0985","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1528-1157.1997.tb01197.x","article-title":"Three patterns of catamenial epilepsy","volume":"38","author":"Herzog","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib0990","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2009.02.017","article-title":"The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy","volume":"85","author":"Reddy","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tips.2016.04.003_bib0995","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.016","article-title":"Neuroendocrine aspects of catamenial epilepsy","volume":"63","author":"Reddy","year":"2013","journal-title":"Hormones & Behav."},{"key":"10.1016\/j.tips.2016.04.003_bib1000","doi-asserted-by":"crossref","first-page":"B198","DOI":"10.1016\/j.nbd.2014.06.010","article-title":"Neurosteroids and their role in sex-specific epilepsies","volume":"72","author":"Reddy","year":"2014","journal-title":"Neurobiol. Disease"},{"issue":"Suppl.11","key":"10.1016\/j.tips.2016.04.003_bib1005","first-page":"126","article-title":"Gender differences in antiseizure sensitivity of neurosteroids in the pilocarpine model of status epilepticus","volume":"50","author":"Reddy","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib1010","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0b013e318259e1f9","article-title":"Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial","volume":"78","author":"Herzog","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2016.04.003_bib1015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.seizure.2015.02.024","article-title":"Catamenial epilepsy: update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial","volume":"28","author":"Herzog","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.tips.2016.04.003_bib1020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1528-1157.2001.10100.x","article-title":"Neurosteroid withdrawal model of perimenstrual catamenial epilepsy","volume":"42","author":"Reddy","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib1025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/ebeh.2001.0271","article-title":"A prospective evaluation of the effects of a 12-week outpatient exercise program on clinical and behavioral outcomes in patients with epilepsy","volume":"2","author":"McAuley","year":"2001","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.tips.2016.04.003_bib1030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nurt.2009.01.006","article-title":"Neurosteroid replacement therapy for catamenial epilepsy","volume":"6","author":"Reddy","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2016.04.003_bib1035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuroscience.2010.07.037","article-title":"Neurosteroid withdrawal regulates GABA-A receptor alpha4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway","volume":"170","author":"Gangisetty","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2016.04.003_bib1040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.112.192377","article-title":"A mouse kindling model of perimenstrual catamenial epilepsy","volume":"341","author":"Reddy","year":"2012","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib1045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuropharm.2004.09.002","article-title":"Anxiolytic activity of progesterone in progesterone receptor knockout mice","volume":"48","author":"Reddy","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1050","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA-A receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib1055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrn2370","article-title":"GABA-A receptor trafficking and its role in the dynamic modulation of neuronal inhibition","volume":"9","author":"Jacob","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl. 6","key":"10.1016\/j.tips.2016.04.003_bib1060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.tips.2016.04.003_bib1065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/epi.12286","article-title":"SGE-102: a novel therapy for refractory status epilepticus","volume":"54","author":"Reddy","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib1070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1358\/dot.2002.38.7.820115","article-title":"The clinical potentials of endogenous neurosteroids","volume":"38","author":"Reddy","year":"2002","journal-title":"Drugs Today"},{"key":"10.1016\/j.tips.2016.04.003_bib1075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.tips.2016.04.003_bib1080","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1528-1167.2011.03220.x","article-title":"Validation of the rat model of cryptogenic infantile spasms","volume":"52","author":"Chachua","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib1085","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.eplepsyres.2014.08.015","article-title":"A potential effect of ganaxolone in an animal model of infantile spasms","volume":"108","author":"Yum","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tips.2016.04.003_bib1090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0074-7742(02)49014-9","article-title":"Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis","volume":"49","author":"Rogawski","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.tips.2016.04.003_bib1095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-1211(00)00170-4","article-title":"Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial","volume":"42","author":"Kerrigan","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tips.2016.04.003_bib1100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2016.04.003_bib1105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1474-4422(06)70676-7","article-title":"Fragile-X syndrome and fragile X-associated tremor\/ataxia syndrome: two faces of FMR1","volume":"6","author":"Jacquemont","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2016.04.003_bib1110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1866-1955-6-25","article-title":"Mouse models of the fragile X premutation and fragile X-associated tremor\/ataxia syndrome","volume":"6","author":"Berman","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.tips.2016.04.003_bib1115","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/dds118","article-title":"Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone","volume":"21","author":"Cao","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2016.04.003_bib1120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2217\/WHE.13.62","article-title":"Treatment of premenstrual dysphoric disorder","volume":"9","author":"Rapkin","year":"2013","journal-title":"Women's Health"},{"key":"10.1016\/j.tips.2016.04.003_bib1125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0015-0282(16)60973-1","article-title":"Transfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP)","volume":"52","author":"Schmidt","year":"1989","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tips.2016.04.003_bib1130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuropharm.2005.04.026","article-title":"Short-term steroid treatment increases delta GABA-A receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects","volume":"49","author":"Shen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1135","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1007\/s00213-014-3599-x","article-title":"Allopregnanolone as a mediator of affective switching in reproductive mood disorders","volume":"231","author":"Schiller","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/npp.2015.246","article-title":"5alpha-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder","volume":"41","author":"Martinez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-0327(86)90035-2","article-title":"Premenstrual changes: patterns and correlates of daily ratings","volume":"10","author":"Endicott","year":"1986","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2016.04.003_bib1150","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1682\/JRRD.2013.01.0006","article-title":"Traumatic brain injury, posttraumatic stress disorder, and pain diagnoses in OIF\/OEF\/OND Veterans","volume":"50","author":"Cifu","year":"2013","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.tips.2016.04.003_bib1155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0024-3205(92)90095-7","article-title":"Analgesic effects of intrathecally-administered 3alpha-hydroxy-5alpha-pregnan-20-one in a rat mechanical visceral pain model","volume":"50","author":"Winfree","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2016.04.003_bib1160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/j.1532-2149.2013.00367.x","article-title":"Etifoxine stimulates allopregnanolone synthesis in the spinal cord to produce analgesia in experimental mononeuropathy","volume":"18","author":"Aouad","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.tips.2016.04.003_bib1165","first-page":"25","article-title":"Allopregnanolone levels are inversely associated with self-reported pain symptoms in U.S. Iraq and Afghanistan-era veterans: Implications for biomarkers and therapeutics","volume":"17","author":"Naylor","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.tips.2016.04.003_bib1170","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2016.04.003_bib1175","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1523\/JNEUROSCI.20-05-01982.2000","article-title":"Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol","volume":"20","author":"VanDoren","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2016.04.003_bib1180","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1530-0277.1999.tb04094.x","article-title":"Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action?","volume":"23","author":"Morrow","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.tips.2016.04.003_bib1185","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0091-3057(94)90197-X","article-title":"Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze","volume":"48","author":"Melchior","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tips.2016.04.003_bib1190","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1530-0277.2008.00718.x","article-title":"Inhibition of 5alpha-reduced steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL\/6J mice","volume":"32","author":"Ford","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.tips.2016.04.003_bib1195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0306-4530(03)00056-8","article-title":"Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation","volume":"29","author":"Meieran","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tips.2016.04.003_bib1200","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1007\/s00213-014-3487-4","article-title":"Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment","volume":"231","author":"Covault","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1205","doi-asserted-by":"crossref","first-page":"e0128313","DOI":"10.1371\/journal.pone.0128313","article-title":"Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease","volume":"10","author":"Irwin","year":"2015","journal-title":"PloS ONE"},{"key":"10.1016\/j.tips.2016.04.003_bib1210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrendo.2013.31","article-title":"Neurosteroids as regenerative agents in the brain: therapeutic implications","volume":"9","author":"Brinton","year":"2013","journal-title":"Nature Reviews in Endocrinolology"},{"key":"10.1016\/j.tips.2016.04.003_bib1215","series-title":"Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths 2002-2006","author":"Faul","year":"2010"},{"key":"10.1016\/j.tips.2016.04.003_bib1220","series-title":"In Translational Research in Traumatic Brain Injury","article-title":"Neurosteroids and traumatic brain injury: translating biomarkers to therapeutics; overview and pilot investigations in Iraq and Afghanistan era veterans","author":"Marx","year":"2016"},{"key":"10.1016\/j.tips.2016.04.003_bib1225","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tips.2016.04.003_bib1230","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/npp.2014.138","article-title":"A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression","volume":"39","author":"Brown","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1037\/a0038747","article-title":"Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women","volume":"23","author":"Allen","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2016.04.003_bib1240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/ecp.13.14","article-title":"The pathophysiological and pharmacological basis of current drug treatment of migraine headache","volume":"6","author":"Reddy","year":"2013","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2016.04.003_bib1245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0896-6273(93)90156-L","article-title":"Progesterone receptor-mediated effects of neuroactive steroids","volume":"11","author":"Rupprecht","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2016.04.003_bib1250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.104.065268","article-title":"Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice","volume":"310","author":"Reddy","year":"2004","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.tips.2016.04.003_bib1255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2004.08.002","article-title":"Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol","volume":"129","author":"Reddy","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2016.04.003_bib1260","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eplepsyres.2010.01.009","article-title":"Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model","volume":"89","author":"Reddy","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tips.2016.04.003_bib1265","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0028-3908(99)00190-2","article-title":"Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate","volume":"39","author":"Gasior","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2016.04.003_bib1270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)02086-7","article-title":"Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice","volume":"474","author":"Kaminski","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2016.04.003_bib1275","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J. Pharmacol. Exp. Therap"},{"key":"10.1016\/j.tips.2016.04.003_bib1280","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00001756-200403010-00026","article-title":"Anticonvulsant activity of the testosterone-derived neurosteroid 3\u03b1-androstanediol","volume":"15","author":"Reddy","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.tips.2016.04.003_bib1285","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90077-0","article-title":"Anticonvulsant profile of the progesterone metabolite 5\u03b1-pregnan-3\u03b1-ol-20-one","volume":"166","author":"Belelli","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2016.04.003_bib1290","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1157.2000.tb00244.x","article-title":"Effect of ganaxolone on flurothyl seizures in developing rats","volume":"41","author":"Liptakova","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib1295","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0028-3908(96)00021-4","article-title":"Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice","volume":"35","author":"Kokate","year":"1996","journal-title":"Neuropharmacology"},{"issue":"Suppl. 7","key":"10.1016\/j.tips.2016.04.003_bib1300","first-page":"3.055","article-title":"Neuroactive steroid therapy of status epilepticus in epilepsy rats","volume":"49","author":"Briyal","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2016.04.003_bib1310","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00036-2","article-title":"Steroid receptor-mediated eff ects of neuroactive steroids: characterization of structure\u2013activity relationship","volume":"303","author":"Rupprecht","year":"1996","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.tips.2016.04.003_bib1305","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication\u2013a pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614716300049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614716300049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T01:01:45Z","timestamp":1748912505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614716300049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":131,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0165614716300049"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2016.04.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Potential of Neurosteroids for CNS Disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}